(HCSG) Healthcare - Ratings and Ratios
Housekeeping,Laundry,Dietary,Facility,Services
HCSG EPS (Earnings per Share)
HCSG Revenue
Description: HCSG Healthcare
Healthcare Services Group Inc (HCSG) is a US-based company operating in the Diversified Support Services sub-industry, providing various services to the healthcare sector. The companys stock performance is characterized by a relatively stable price movement, with a beta of 0.538, indicating lower volatility compared to the overall market.
The income tax expense of HCSG is a critical component of its financials, influencing its net income and profitability. Analyzing the yearly income tax expense can provide insights into the companys tax strategy and its impact on earnings. Key drivers of income tax expense include changes in tax laws, the companys geographical footprint, and its operational structure.
To evaluate HCSGs performance, key performance indicators (KPIs) such as revenue growth, operating margin, and return on equity (ROE) are essential. The companys ROE of 2.18% suggests that HCSG may be facing challenges in generating returns for its shareholders. However, its forward P/E ratio of 17.57 indicates that the market expects improved earnings in the future.
Economic drivers influencing HCSGs business include the demand for healthcare services, government policies and regulations, and the overall economic environment. The aging population and the resulting increase in healthcare needs are positive drivers for the company. Conversely, changes in healthcare policies and reimbursement rates can negatively impact HCSGs revenue and profitability.
To assess the companys valuation, metrics such as the price-to-earnings (P/E) ratio and market capitalization are useful. HCSGs market capitalization of $1.092 billion and P/E ratio of 107.79 suggest that the stock may be overvalued, although the forward P/E ratio indicates potential for earnings growth. A comprehensive analysis of HCSGs financials, industry trends, and economic drivers is necessary to determine the companys intrinsic value and investment potential.
HCSG Stock Overview
| Market Cap in USD | 1,160m |
| Sub-Industry | Diversified Support Services |
| IPO / Inception | 1990-03-26 |
HCSG Stock Ratings
| Growth Rating | 21.2% |
| Fundamental | 59.2% |
| Dividend Rating | 15.1% |
| Return 12m vs S&P 500 | 13.9% |
| Analyst Rating | 3.80 of 5 |
HCSG Dividends
Currently no dividends paidHCSG Growth Ratios
| Growth Correlation 3m | 65.3% |
| Growth Correlation 12m | 67% |
| Growth Correlation 5y | -77.1% |
| CAGR 5y | 5.42% |
| CAGR/Max DD 3y | 0.13 |
| CAGR/Mean DD 3y | 0.25 |
| Sharpe Ratio 12m | 0.41 |
| Alpha | 0.12 |
| Beta | 0.002 |
| Volatility | 35.56% |
| Current Volume | 488.3k |
| Average Volume 20d | 646.2k |
| Stop Loss | 15 (-3.6%) |
| Signal | 0.01 |
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (10.8m TTM) > 0 and > 6% of Revenue (6% = 106.3m TTM) |
| FCFTA 0.11 (>2.0%) and ΔFCFTA 6.85pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 17.97% (prev 21.59%; Δ -3.62pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.12 (>3.0%) and CFO 96.8m > Net Income 10.8m (YES >=105%, WARN >=100%) |
| Net Debt (-105.4m) to EBITDA (35.0m) ratio: -3.01 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.49 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (73.4m) change vs 12m ago -0.59% (target <= -2.0% for YES) |
| Gross Margin 10.89% (prev 15.11%; Δ -4.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 221.3% (prev 210.7%; Δ 10.55pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.30 (EBITDA TTM 35.0m / Interest Expense TTM 3.54m) >= 6 (WARN >= 3) |
Altman Z'' 4.29
| (A) 0.40 = (Total Current Assets 532.3m - Total Current Liabilities 213.9m) / Total Assets 802.2m |
| (B) 0.26 = Retained Earnings (Balance) 209.5m / Total Assets 802.2m |
| (C) 0.02 = EBIT TTM 18.7m / Avg Total Assets 801.0m |
| (D) 0.64 = Book Value of Equity 208.8m / Total Liabilities 325.2m |
| Total Rating: 4.29 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.21
| 1. Piotroski 7.0pt = 2.0 |
| 2. FCF Yield 6.88% = 3.44 |
| 3. FCF Margin 5.13% = 1.28 |
| 4. Debt/Equity 0.68 = 2.27 |
| 5. Debt/Ebitda 9.29 = -2.50 |
| 6. ROIC - WACC (= -1.94)% = -2.42 |
| 7. RoE 2.18% = 0.18 |
| 8. Rev. Trend 84.69% = 6.35 |
| 9. EPS Trend -28.05% = -1.40 |
What is the price of HCSG shares?
Over the past week, the price has changed by -1.61%, over one month by +1.63%, over three months by +7.31% and over the past year by +34.95%.
Is Healthcare a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HCSG is around 15.47 USD . This means that HCSG is currently overvalued and has a potential downside of -0.58%.
Is HCSG a buy, sell or hold?
- Strong Buy: 2
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HCSG price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 17.3 | 11.4% |
| Analysts Target Price | 17.3 | 11.4% |
| ValueRay Target Price | 16.7 | 7.1% |
Last update: 2025-09-15 04:37
HCSG Fundamental Data Overview
CCE Cash And Equivalents = 164.1m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 114.4286
P/E Forward = 16.2602
P/S = 0.6546
P/B = 2.4318
P/EG = 2.3893
Beta = 0.66
Revenue TTM = 1.77b USD
EBIT TTM = 18.7m USD
EBITDA TTM = 35.0m USD
Long Term Debt = 111.2m USD (from nonCurrentLiabilitiesTotal, last quarter)
Short Term Debt = 213.9m USD (from totalCurrentLiabilities, last quarter)
Debt = 325.2m USD (Calculated: Short Term 213.9m + Long Term 111.2m)
Net Debt = -105.4m USD (from netDebt column, last quarter)
Enterprise Value = 1.32b USD (1.16b + Debt 325.2m - CCE 164.1m)
Interest Coverage Ratio = 5.30 (Ebit TTM 18.7m / Interest Expense TTM 3.54m)
FCF Yield = 6.88% (FCF TTM 90.9m / Enterprise Value 1.32b)
FCF Margin = 5.13% (FCF TTM 90.9m / Revenue TTM 1.77b)
Net Margin = 0.61% (Net Income TTM 10.8m / Revenue TTM 1.77b)
Gross Margin = 10.89% ((Revenue TTM 1.77b - Cost of Revenue TTM 1.58b) / Revenue TTM)
Tobins Q-Ratio = 6.33 (Enterprise Value 1.32b / Book Value Of Equity 208.8m)
Interest Expense / Debt = 0.13% (Interest Expense 418.0k / Debt 325.2m)
Taxrate = 25.44% (13.5m / 52.9m)
NOPAT = 14.0m (EBIT 18.7m * (1 - 25.44%))
Current Ratio = 2.49 (Total Current Assets 532.3m / Total Current Liabilities 213.9m)
Debt / Equity = 0.68 (Debt 325.2m / last Quarter total Stockholder Equity 477.0m)
Debt / EBITDA = 9.29 (Net Debt -105.4m / EBITDA 35.0m)
Debt / FCF = 3.58 (Debt 325.2m / FCF TTM 90.9m)
Total Stockholder Equity = 495.0m (last 4 quarters mean)
RoA = 1.35% (Net Income 10.8m, Total Assets 802.2m )
RoE = 2.18% (Net Income TTM 10.8m / Total Stockholder Equity 495.0m)
RoCE = 3.09% (Ebit 18.7m / (Equity 495.0m + L.T.Debt 111.2m))
RoIC = 2.79% (NOPAT 14.0m / Invested Capital 501.2m)
WACC = 4.72% (E(1.16b)/V(1.49b) * Re(6.02%)) + (D(325.2m)/V(1.49b) * Rd(0.13%) * (1-Tc(0.25)))
Shares Correlation 3-Years: -51.52 | Cagr: -0.11%
Discount Rate = 6.02% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 70.46% ; FCFE base≈68.9m ; Y1≈45.2m ; Y5≈20.7m
Fair Price DCF = 5.61 (DCF Value 406.4m / Shares Outstanding 72.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -28.05 | EPS CAGR: -69.58% | SUE: -4.0 | # QB: 0
Revenue Correlation: 84.69 | Revenue CAGR: 3.74% | SUE: 1.62 | # QB: 1
Additional Sources for HCSG Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle